Engineering antibodies for therapyADAIR, J. R.Immunological reviews. 1992, Vol 130, pp 5-40, issn 0105-2896Article

Engineering antibodies for therapyMOUNTAIN, A; ADAIR, J. R.Biotechnology & genetic engineering reviews. 1992, Vol 10, pp 1-142, issn 0264-8725Article

Site-specific attachment to recombinant antibodies via introduced surface cysteine residuesLYONS, A; KING, D. J; OWENS, R. J et al.Protein engineering (Print). 1990, Vol 3, Num 8, pp 703-708, issn 0269-2139, 6 p.Article

Infrared, thermistor, and glass-mercury thermometry for measurement of body temperature in children with cancerSHENEP, J. L; ADAIR, J. R; HUGHES, W. T et al.Clinical pediatrics. 1991, Vol 30, Num 4, pp 36-41, issn 0009-9228, SUPConference Paper

Isotype choice for chimeric antibodies affects binding propertiesMORELOCK, M. M; ROTHLEIM, R; WRIGHT, J. L et al.The Journal of biological chemistry (Print). 1994, Vol 269, Num 17, pp 13048-13055, issn 0021-9258Article

Improved tumor targeting with chemically cross-linked recombinant antibody fragmentsKING, D. J; TURNER, A; MILLAR, K et al.Cancer research (Baltimore). 1994, Vol 54, Num 23, pp 6176-6185, issn 0008-5472Article

Tumor localization of engineered antibody fragmentsKING, D. J; MOUNTAIN, A; PEDLEY, B et al.Antibody immunoconjugates, and radiopharmaceuticals. 1992, Vol 5, Num 2, pp 159-170, issn 0892-7049Article

Humanized OKT3 antibodies : successful transfer of immune modulating properties and idiotype expressionSTEVE WOODLE, E; RICHARD THISTLETWAITE, J; JOLLIFFE, L. K et al.The Journal of immunology (1950). 1992, Vol 148, Num 9, pp 2756-2763, issn 0022-1767Article

A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibodyANGAL, S; KING, D. J; BODMER, M. W et al.Molecular immunology. 1993, Vol 30, Num 1, pp 105-108, issn 0161-5890Article

Crystal structure of a chimeric Fab' fragment of an antibody binding tumour cellsBRADY, R. L; EDWARDS, D. J; LOW, D. C et al.Journal of molecular biology. 1992, Vol 227, Num 1, pp 253-264, issn 0022-2836Article

Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab' fragmentKING, D. J; ADAIR, J. R; ANGAL, S et al.Biochemical journal (London. 1984). 1992, Vol 281, pp 317-323, issn 0264-6021, 2Article

A humanized antibody against human cytomegalovirus (CMV) gpUL75 (gH) for prophylaxis or treatment of CMV infectionsHAMILTON, A. A; MANUEL, D. M; GRUNDY, J. E et al.The Journal of infectious diseases. 1997, Vol 176, Num 1, pp 59-68, issn 0022-1899Article

Preparation and preclinical evaluation of humanised A33 immunoconjugates for radioimmunotherapyKING, D. J; ANTONIW, P; BALDOCK, D et al.British journal of cancer. 1995, Vol 72, Num 6, pp 1364-1372, issn 0007-0920Article